Quick generic drug application bulletin for today. If you or a loved one suffers from hay fever or other allergies, this is important generic drug news. Perrigo has announced that it has filed an application with the Food and Drug Administration (FDA) for a generic version of Alcon Laboratories’ prescription nasal spray Patanase which treats seasonal nasal allergies.
According to the Mayo Clinic, hay fever, also called allergic rhinitis, causes cold-like signs and symptoms such as a runny nose, congestion, sneezing and sinus pressure. But unlike a cold, hay fever isn’t caused by a virus. Hay fever is caused by an allergic response to outdoor or indoor allergens, such as pollen, dust mites or pet dander. Hay fever is common — it affects more than 1 in 5 people. Some people have symptoms year-round. For others, hay fever symptoms get worse at certain times of the year, usually in the spring, summer or fall.
Considering a thirty-day supply of brand-name Patanase is currently running almost $135, a generic version of Patanase could easily be a major savings for many allergy-sufferers. As allergy sufferers ourselves, you can be sure that we’ll be keeping an eye on this one!
Do you suffer from seasonal allergies? Tell us about it!
- Generic Drug News: Application Filed for Generic Version of Cancer Drug Tykerb
- Generic Drug News: Application Filed for Generic Version of Prostate Drug Jalyn
- Generic Drug News: Mylan Starts Selling Generic Version of Prostate Drug Uroxatral
- Generic Drug News: GlaxoSmithKline Files Lawsuit to Stop Generic Version of Prostate Drug Avodart
- Generic Drug News: Endo Files Lawsuit to Block Generic Version of Migraine Drug Frova